Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples